1New drugs approved globally in 2016: retrospect and prospectYANG Zhen-zheng, SUN You-song, XING Ai-min, KANG Yin-hua, ZHENG Xiao-nan, GU Jue-fen601-6132Study on the PRIority MEdicines in the European UnionSHAO Rong, SUN Hai-shun, YAN Jian-zhou, WANG Meng-yuan614-6193The validation of an indicator system of essential drug accessibility assessment in ChinaXI Xiao-yu, CHEN Piao-piao, MA Dan-dan, MAO Ning-ying620-6254Research on policy environment of pharmaceutical industry innovation under reform of the supply front base on American experienceYAN Jian-zhou, WANG Meng-yuan, SHAO Rong626-6305Advances in respiratory syncytial virus infection animal models for pharmacodynamic evaluation of related drugsSHAN Xiao-lei, SUN Tao, YU Chun-rong, WANG Qing-li631-6346The application prospects of provantis system Dispense module in the management of test article in non-clinical drug safety evaluationXIONG Ke-zhao, ZHANG Wen-hao, HAN Gang, DONG Yan-sheng, WANG Xiao-fei, WNAG Quan-jun635-6387Effect of fluorofenidone on inhibiting scar formation in rat cutaneous woundsXU Qi-rong, WANG Sheng-feng, LUO Li-na, DING Jin-song, ZHOU Yan-bin639-6438Research advances in mechanisms of resistance to arsenic trioxide in acute promyelocytic leukemiaJIN Bo, YANG Kun-peng, ZHOU Jin644-6479Clinical research progress in drug treatment of Alzheimer's diseaseLI Hui648-65510Clinical observation study of butyphthalide for massive cerebral infarctionLIN Ya-nan, ZHANG Ya, WANG Yu, YU Ruo-mei, GUO Yan, SUN Xiao-pei656-66011Clinical observation of oxycodone hydrochloride injection for acute pain during anesthesia recovery period after lower abdominal surgeryYAO Yue-qin, LIU Ying-hua, FAN Zhi-yi661-66412Intestinal absorption kinetics of candidate drug HY152-J in rats in vivo665-66913Oxymatrine improves fat-induced insulin resistance of ApoE-/-mice by inhibiting inflammatory cytokinesWANG Chao, ZHANG Hui-xin, XING Han-ying, WANG Xing, ZHANG Zhe670-67414Antitussive, expectorant and anti-inflammatory effects of butylphthalide in miceWANG Zhi-wang, FU Xiao-yan, REN Yuan, WANG Yong-hui, LIN Xing-yao, WANG Rui-qiong675-67915The pharmacokinetic interactions of rivaroxaban and repaglinide in ratsJIANG Da-peng, DONG Wei-chong, HE Wen-juan, GONG Ying, ZHANG Zhi-qing, WANG Shu-mei680-68516Pharmacokinetics of emodin liposomes mixed with different forms of PEG in ratsSHEN Li-ping, YAN Dong-xue, ZHAO Shan-ke, YIN Mei-lin, SUN Yu-qi686-69117Folate-decorated nanostructured lipid carriers for pDNA targeting ovarian cancerYU Wang-yang, LI Chang-jun, LI Yong-gang692-69718Comparison of intracellular kinetics of two kinds of PLGA nanoparticles with different zeta sizesCUI Ya-nan, YANG Xiao-qin, ZHANG Zhi-yun, DONG Hao, SHAN Kun698-70319An HPLC method for determination of the content of purinostat dihydrochloride bulk drugXU Jun-peng, PAN Chao, TANG Qiao-xin, WAN Li704-70820Rapid determination of linderane and norisoboldine in Radix Linderae by near-infrared spectrometryDU Wei-feng, WU Yao, YUE Xian-ke, LING Jue, GU Chao, GE Wei-hong709-715 